Concurrently, tumor cell-derived lactate can enter the neighboring normoxic cancer cells via MCT1 for OXPHOS, thus sparing glucose for glycolytic cancer cells (Sonveaux et al., 2008; Doherty and Cleveland, 2013). Here, SLC16A1 is linked to cancer.